[go: up one dir, main page]

IL135256A0 - 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) - Google Patents

2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)

Info

Publication number
IL135256A0
IL135256A0 IL13525698A IL13525698A IL135256A0 IL 135256 A0 IL135256 A0 IL 135256A0 IL 13525698 A IL13525698 A IL 13525698A IL 13525698 A IL13525698 A IL 13525698A IL 135256 A0 IL135256 A0 IL 135256A0
Authority
IL
Israel
Prior art keywords
ht1d
ht1b
ht1a
substituted
serotonin antagonists
Prior art date
Application number
IL13525698A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL135256A0 publication Critical patent/IL135256A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL13525698A 1997-10-22 1998-10-05 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) IL135256A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746612A DE19746612A1 (de) 1997-10-22 1997-10-22 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/006300 WO1999020616A1 (de) 1997-10-22 1998-10-05 2-substituierte 1,2-benzisothiazol-derivate und ihre verwendung als serotonin-antagonisten (5-ht1a, 5-ht1b und 5-ht1d)

Publications (1)

Publication Number Publication Date
IL135256A0 true IL135256A0 (en) 2001-05-20

Family

ID=7846266

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13525698A IL135256A0 (en) 1997-10-22 1998-10-05 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)

Country Status (23)

Country Link
US (1) US6346622B1 (es)
EP (1) EP1034170A1 (es)
JP (1) JP2001520224A (es)
KR (1) KR20010031297A (es)
CN (1) CN1277607A (es)
AR (1) AR016968A1 (es)
AU (1) AU748613B2 (es)
BG (1) BG104332A (es)
BR (1) BR9812948A (es)
CA (1) CA2307199A1 (es)
CO (1) CO4980863A1 (es)
DE (1) DE19746612A1 (es)
HR (1) HRP980555A2 (es)
HU (1) HUP0003758A3 (es)
IL (1) IL135256A0 (es)
NO (1) NO20001937L (es)
NZ (1) NZ503604A (es)
PL (1) PL340033A1 (es)
SK (1) SK4572000A3 (es)
TR (1) TR200001080T2 (es)
TW (1) TW517052B (es)
WO (1) WO1999020616A1 (es)
ZA (1) ZA989571B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
AP2005003250A0 (en) * 2002-09-17 2005-03-31 Warner Lambert Co Heterocyclic substituted piperazines for the treatment of schizophrenia.
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
ATE479683T1 (de) 2002-11-05 2010-09-15 Glaxo Group Ltd Antibakterielle mittel
KR100472988B1 (ko) 2002-11-27 2005-03-10 씨제이 주식회사 조직감, 취반성 및 안전성이 우수한 발아 현미의 제조방법및 이로부터 얻은 발아 현미
CN101151249B (zh) * 2005-03-31 2011-04-06 辉瑞产品公司 环戊吡啶及四氢喹啉衍生物
EP2376453B1 (en) * 2008-12-11 2019-11-20 VIIV Healthcare Company Intermediates for carbamoylpyridone hiv integrase inhibitors
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8601494A (nl) 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.
DE3620643A1 (de) * 1985-06-22 1987-01-22 Sandoz Ag Thiazole, ihre herstellung und verwendung
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
JPH0912562A (ja) * 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体

Also Published As

Publication number Publication date
NZ503604A (en) 2002-03-01
AR016968A1 (es) 2001-08-01
CA2307199A1 (en) 1999-04-29
JP2001520224A (ja) 2001-10-30
BR9812948A (pt) 2000-08-08
WO1999020616A1 (de) 1999-04-29
AU1149799A (en) 1999-05-10
HRP980555A2 (en) 1999-08-31
PL340033A1 (en) 2001-01-15
NO20001937D0 (no) 2000-04-13
HUP0003758A1 (hu) 2001-10-28
US6346622B1 (en) 2002-02-12
CN1277607A (zh) 2000-12-20
ZA989571B (en) 2000-04-25
TW517052B (en) 2003-01-11
NO20001937L (no) 2000-04-13
BG104332A (en) 2001-02-28
CO4980863A1 (es) 2000-11-27
DE19746612A1 (de) 1999-04-29
KR20010031297A (ko) 2001-04-16
SK4572000A3 (en) 2000-10-09
AU748613B2 (en) 2002-06-06
EP1034170A1 (en) 2000-09-13
TR200001080T2 (tr) 2001-01-22
HUP0003758A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
IS4813A (is) Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka
AU4337699A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT4 receptors
ATE240327T1 (de) 1,2-annelierte chinolinderivate
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
AU5265599A (en) Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
EP1001006A4 (en) AQUEOUS COMPOSITION, AQUEOUS CUTTING FLUID, METHOD FOR THE PRODUCTION AND USE
HUP0103673A3 (en) Substituted phenyl derivatives, their preparation and use
HUP9904167A3 (en) 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
ATE266637T1 (de) 3,3-biarylpiperidin- und 3,3- biarylmorpholinderivate
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
IL135256A0 (en) 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
HUP0100926A3 (en) Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
AU4493496A (en) Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
AU9068398A (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists
IL156174A0 (en) 1,2,4-oxadizaole derivatives as hppar alpha agonists
ID27976A (id) 4,5,6 dan 7-indol dan turunan-turunan indolin, pembuatan dan penggunaannya
AU2197695A (en) Dimeric benzimidazole derivatives, their preparation and their use as dopaminergic agents, esp. selective for the dopamine d3 receptor
AU2883397A (en) 5-alkoxy-tryptamine derivatives, their preparation and their use as 5-ht1d receptor agonists
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
AU1970800A (en) 1,4-benzodiazepinone derivatives and their use as integrin antagonists
AU3147500A (en) Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
FI973631A7 (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
AU5663598A (en) 2,1,3-benzothia(oxa)diazole derivatives and their use as endothelin-receptor antagonists